Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease

OBJECTIVES: We have reported increased 2.6-year mortality in clarithromycin- versus placebo-exposed stable coronary heart disease patients, but meta-analysis of randomized trials in coronary heart disease patients showed no significant effect of antibiotics on mortality. Here we report the 6-year mo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Gluud, Christian, Als-Nielsen, Bodil, Damgaard, Morten, Fischer Hansen, Jørgen, Hansen, Stig, Helø, Olav H., Hildebrandt, Per, Hilden, Jørgen, Jensen, Gorm Boje, Kastrup, Jens, Kolmos, Hans Jørn, Kjøller, Erik, Lind, Inga, Nielsen, Henrik, Petersen, Lars, Jespersen, Christian M.
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger AG 2008
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2820332/
https://ncbi.nlm.nih.gov/pubmed/18451646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000128994
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы